397 related articles for article (PubMed ID: 30768203)
1. Feasibility and Early Outcomes of a Tailored Quitline Protocol for Smokers With Mental Health Conditions.
Carpenter KM; Nash CM; Vargas-Belcher RA; Vickerman KA; Haufle V
Nicotine Tob Res; 2019 Apr; 21(5):584-591. PubMed ID: 30768203
[TBL] [Abstract][Full Text] [Related]
2. Quitline Use and Outcomes among Callers with and without Mental Health Conditions: A 7-Month Follow-Up Evaluation in Three States.
Vickerman KA; Schauer GL; Malarcher AM; Zhang L; Mowery P; Nash CM
Biomed Res Int; 2015; 2015():817298. PubMed ID: 26273647
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Comorbid Health Conditions and Quit Outcomes Among Smokers Enrolled in a State Quitline, Arizona, 2011-2016.
Nair US; Bell ML; Yuan NP; Wertheim BC; Thomson CA
Public Health Rep; 2018; 133(2):200-206. PubMed ID: 29570436
[TBL] [Abstract][Full Text] [Related]
4. American Indian/Alaska Native Smokers' Utilization of a Statewide Tobacco Quitline: Engagement and Quitting Behaviors From 2008 to 2018.
Lienemann BA; Cummins SE; Tedeschi GJ; Wong S; Zhu SH
Nicotine Tob Res; 2021 Jan; 23(1):219-226. PubMed ID: 31711234
[TBL] [Abstract][Full Text] [Related]
5. Quitline Outcomes for Smokers in 6 States: Rates of Successful Quitting Vary by Mental Health Status.
Lukowski AV; Morris CD; Young SE; Tinkelman D
Nicotine Tob Res; 2015 Aug; 17(8):924-30. PubMed ID: 26180216
[TBL] [Abstract][Full Text] [Related]
6. Tobacco User Characteristics and Outcomes Related to Intensity of Quitline Program Use: Results From Minnesota and Pennsylvania.
Lien RK; Schillo BA; Mast JL; Lukowski AV; Greenseid LO; Keith JD; Keller PA
J Public Health Manag Pract; 2016; 22(5):E36-46. PubMed ID: 27479313
[TBL] [Abstract][Full Text] [Related]
7. Using a quitline plus low-cost nicotine replacement therapy to help disadvantaged smokers to quit.
Miller CL; Sedivy V
Tob Control; 2009 Apr; 18(2):144-9. PubMed ID: 19131454
[TBL] [Abstract][Full Text] [Related]
8. Cessation Outcomes Among Quitline Callers in Three States During a National Tobacco Education Campaign.
Vickerman KA; Zhang L; Malarcher A; Mowery P; Nash C
Prev Chronic Dis; 2015 Jul; 12():E110. PubMed ID: 26182145
[TBL] [Abstract][Full Text] [Related]
9. Nicotine Withdrawal, Relapse of Mental Illness, or Medication Side-Effect? Implementing a Monitoring Tool for People With Mental Illness Into Quitline Counseling.
Segan CJ; Baker AL; Turner A; Williams JM
J Dual Diagn; 2017; 13(1):60-66. PubMed ID: 28067594
[TBL] [Abstract][Full Text] [Related]
10. Cessation among state quitline participants with a mental health condition.
Kerkvliet JL; Wey H; Fahrenwald NL
Nicotine Tob Res; 2015 Jun; 17(6):735-41. PubMed ID: 25385874
[TBL] [Abstract][Full Text] [Related]
11. Intermediate cessation outcomes among quitline callers during a national tobacco education campaign.
Zhang L; Vickerman K; Malarcher A; Mowery P
Nicotine Tob Res; 2014 Nov; 16(11):1478-86. PubMed ID: 25006045
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Pilot of a Tailored Smoking Cessation Quitline Intervention for Individuals Who Smoke and Vape.
Vickerman KA; Carpenter KM; Miles LN; Hsu JM; Watt KA; Brandon TH; Hart JT; Javitz HS; Wagener TL
Nicotine Tob Res; 2022 Oct; 24(11):1811-1820. PubMed ID: 35575085
[TBL] [Abstract][Full Text] [Related]
13. Quitline Programs Tailored for Mental Health: Initial Outcomes and Feasibility.
Morris CD; Lukowski AV; Vargas-Belcher RA; Ylioja TE; Nash CM; Bailey LA
Am J Prev Med; 2021 Mar; 60(3 Suppl 2):S163-S171. PubMed ID: 33663704
[TBL] [Abstract][Full Text] [Related]
14. Electronic nicotine delivery system (ENDS) use during smoking cessation: a qualitative study of 40 Oklahoma quitline callers.
Vickerman KA; Beebe LA; Schauer GL; Magnusson B; King BA
BMJ Open; 2017 Apr; 7(4):e013079. PubMed ID: 28365587
[TBL] [Abstract][Full Text] [Related]
15. The Medi-Cal Incentives to Quit Smoking Project: Impact of Statewide Outreach Through Health Channels.
Tong EK; Stewart SL; Schillinger D; Vijayaraghavan M; Dove MS; Epperson AE; Vela C; Kratochvil S; Anderson CM; Kirby CA; Zhu SH; Safier J; Sloss G; Kohatsu ND
Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S159-S169. PubMed ID: 30454670
[TBL] [Abstract][Full Text] [Related]
16. Racial/Ethnic Differences in the Response to Incentives for Quitline Engagement.
Vijayaraghavan M; Dove MS; Stewart SL; Cummins SE; Schillinger D; Kohatsu ND; Tong EK
Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S186-S195. PubMed ID: 30454673
[TBL] [Abstract][Full Text] [Related]
17. Giving away free nicotine medications and a cigarette substitute (Better Quit) to promote calls to a quitline.
Bauer JE; Carlin-Menter SM; Celestino PB; Hyland A; Cummings KM
J Public Health Manag Pract; 2006; 12(1):60-7. PubMed ID: 16340517
[TBL] [Abstract][Full Text] [Related]
18. Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.
Smith SS; Keller PA; Kobinsky KH; Baker TB; Fraser DL; Bush T; Magnusson B; Zbikowski SM; McAfee TA; Fiore MC
Nicotine Tob Res; 2013 Mar; 15(3):718-28. PubMed ID: 22992296
[TBL] [Abstract][Full Text] [Related]
19. Marijuana Use and Adherence to Smoking Cessation Treatment Among Callers to Tobacco Quitlines.
Carpenter KM; Torres AJ; Salmon EE; Carlini BH; Vickerman KA; Schauer GL; Bush T
Prev Chronic Dis; 2020 Sep; 17():E102. PubMed ID: 32915131
[TBL] [Abstract][Full Text] [Related]
20. Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.
Vilardaga R; Rizo J; Palenski PE; Mannelli P; Oliver JA; Mcclernon FJ
Nicotine Tob Res; 2020 Aug; 22(9):1533-1542. PubMed ID: 31667501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
